Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

From a Molecule of Natural Origin New Therapeutic Opportunities Against Hypertension

By Istituto Neurologico Mediterraneo Neuromed I.R.C.C.S. | January 3, 2019

Spirulina is more and more celebrated as a “superfood” because of its possible beneficial properties, albeit its mechanism of action is still subjected to investigation. With the scientific name of Arthrospira platensis, spirulina is a cyanobacterium, a bacterium capable of photosynthesis. Sometimes classified as a “blue algae”, it was supposedly used as a food by the Aztecs.

Now a research from the Vascular Physiopathology Laboratory of the I.R.C.C.S. Neuromed in Pozzilli (Italy) shows that one of its extracts may counteract arterial hypertension by dilating blood vessels.

Neuromed researchers, working in collaboration with University of Salerno, Sapienza University of Rome and Federico II University of Naples, isolated from the spirulina extract a peptide (a molecule composed of amino acids, such as proteins, but smaller) capable of dilating arteries, thus leading to antihypertensive action. The study, published in the journal Hypertension, was conducted both in the laboratory, on isolated arteries, and on animal models.

“Our research – says Albino Carrizzo, first author of the paper – started by conducting simulated gastrointestinal digestion on the raw extract of spirulina. In other words, we reproduced what happens in the human gut after ingesting the substance. This way we have been able to isolate the peptides that would be absorbed by our body “.

One of the isolated peptides, named SP6, has been identified for the first time. Administered to isolated blood vessels in the lab, it showed vasodilatory action, a potentially antihypertensive effect. This led researchers to administer SP6 to hypertensive animals, resulting in an effective lowering of blood pressure.

“We know – says Carmine Vecchione, Professor at the University of Salerno and head of Vascular Physiopathology Laboratory at Neuromed Institute – that hypertensive patients often have a defect in the natural processes that, by the action of nitric oxide, regulate endothelium (the inner wall of blood vessels). The peptide we isolated in spirulina extract acts positively on this mechanism. Of course, further researches will be necessary, but we think that SP6 could be a natural adjuvant to common pharmacological therapies in order to improve endothelial function and, consequently, combat hypertension”.

Related Articles Read More >

Rendering of Eli Lilly facility in Lehigh Valley, PA (1)
Lilly to build $3.5B injectable medicine, device manufacturing plant in Pennsylvania
Cellares Logo (1)
Cellares raises $257M to industrialize cell therapy manufacturing
Antheia_Logo (1)
Antheia closes $80M financing to strengthen U.S. drug manufacturing
This is the logo of Johnson & Johnson.
Johnson & Johnson announces new North Carolina pharma plant
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE